GSK plc (GSK) said on Monday that its application for extending the use of its respiratory syncytial virus (RSV) vaccine ...

Sotatercept-csrk was first approved in 2024 to treat pulmonary arterial hypertension (PAH) in adults based on results seen in the phase 3 STELLAR trial.

Veterans Affairs data-based study finds that changing from MDI to DPI is linked to greater healthcare use, though the veteran ...

PORTLAND, IN, UNITED STATES, July 14, 2025 /EINPresswire.com/ -- According to the report published by Allied Market Research, the global intelligent asthma monitoring devices market generated $180.5 ...